BRETT LU: Open Payments
NPI 1649331760 · HONOLULU, HI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,349 in 14 payments from 8 companies in 2025. Trend: 2023 $1,053 · 2024 $719 · 2025 $1,349
Food & beverage: $1,333Education: $17
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 3 | $417 |
| Alkermes, Inc. | 3 | $318 |
| ABBVIE INC. | 2 | $265 |
| E.R. Squibb & Sons, L.L.C. | 2 | $163 |
| Axsome Therapeutics, Inc. | 1 | $119 |
| Lundbeck LLC | 1 | $31 |
| Teva Pharmaceuticals USA, Inc. | 1 | $20 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $17 |
Products named: INGREZZA, VRAYLAR, ARISTADA, COBENFY, Auvelity, LYBALVI, REXULTI, AUSTEDO XR.
Industry payments across HI — which companies pay providers there.
